BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12230496)

  • 1. Cloning and characterization of the expression pattern of a novel splice product MIA (splice) of malignant melanoma-derived growth-inhibiting activity (MIA/CD-RAP) [corrected].
    Hau P; Wise P; Bosserhoff AK; Blesch A; Jachimczak P; Tschertner I; Bogdahn U; Apfel R
    J Invest Dermatol; 2002 Sep; 119(3):562-9. PubMed ID: 12230496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.
    Hau P; Apfel R; Wiese P; Tschertner I; Blesch A; Bogdahn U
    Anticancer Res; 2002; 22(2A):577-83. PubMed ID: 12014625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma.
    Bosserhoff AK; Kondo S; Moser M; Dietz UH; Copeland NG; Gilbert DJ; Jenkins NA; Buettner R; Sandell LJ
    Dev Dyn; 1997 Apr; 208(4):516-25. PubMed ID: 9097023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization and chromosomal assignment of equine cartilage derived retinoic acid sensitive protein (CD-RAP)/melanoma inhibitory activity (MIA).
    Berg LC; Mata X; Thomsen PD
    Gene; 2008 Jan; 407(1-2):98-104. PubMed ID: 17977671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
    Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
    Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
    Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
    Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.
    Bosserhoff AK; Moser M; Hein R; Landthaler M; Buettner R
    J Pathol; 1999 Mar; 187(4):446-54. PubMed ID: 10398105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood.
    de Vries TJ; Fourkour A; Punt CJ; Diepstra H; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 Nov; 81(6):1066-70. PubMed ID: 10576666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA.
    Blesch A; Bosserhoff AK; Apfel R; Behl C; Hessdoerfer B; Schmitt A; Jachimczak P; Lottspeich F; Buettner R; Bogdahn U
    Cancer Res; 1994 Nov; 54(21):5695-701. PubMed ID: 7923218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, function and clinical relevance of MIA (melanoma inhibitory activity).
    Bosserhoff AK; Buettner R
    Histol Histopathol; 2002 Jan; 17(1):289-300. PubMed ID: 11813878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression.
    Poser I; Golob M; Weidner M; Buettner R; Bosserhoff AK
    Cancer Res; 2002 Oct; 62(20):5962-6. PubMed ID: 12384563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTp11, a novel member of the family of human cancer/testis antigens.
    Zendman AJ; Cornelissen IM; Weidle UH; Ruiter DJ; van Muijen GN
    Cancer Res; 1999 Dec; 59(24):6223-9. PubMed ID: 10626816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of melanoma inhibitory activity and other differentially expressed messenger RNAs in human melanoma cell lines with different metastatic capacity by messenger RNA differential display.
    van Groningen JJ; Bloemers HP; Swart GW
    Cancer Res; 1995 Dec; 55(24):6237-43. PubMed ID: 8521420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques.
    Jachimczak P; Apfel R; Bosserhoff AK; Fabel K; Hau P; Tschertner I; Wise P; Schlingensiepen KH; Schuler-Thurner B; Bogdahn U
    Int J Cancer; 2005 Jan; 113(1):88-92. PubMed ID: 15386421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
    Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin.
    Poetsch M; Dittberner T; Cowell JK; Woenckhaus C
    Oncogene; 2000 Nov; 19(50):5817-20. PubMed ID: 11126369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MIA ("melanoma inhibitory activity"). Biological functions and clinical relevance in malignant melanoma].
    Bosserhoff AK; Golob M; Buettner R; Landthaler M; Hein R
    Hautarzt; 1998 Oct; 49(10):762-9. PubMed ID: 9857251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of XAGE-1b, a short major transcript of cancer/testis-associated gene XAGE-1, induced in melanoma metastasis.
    Zendman AJ; van Kraats AA; den Hollander AI; Weidle UH; Ruiter DJ; van Muijen GN
    Int J Cancer; 2002 Jan; 97(2):195-204. PubMed ID: 11774264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of mesenchymal stem cell and chondrocyte differentiation by MIA.
    Tscheudschilsuren G; Bosserhoff AK; Schlegel J; Vollmer D; Anton A; Alt V; Schnettler R; Brandt J; Proetzel G
    Exp Cell Res; 2006 Jan; 312(1):63-72. PubMed ID: 16256983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.